Ignite Creation Date:
2025-12-24 @ 4:52 PM
Ignite Modification Date:
2025-12-28 @ 12:32 AM
Study NCT ID:
NCT05485350
Status:
UNKNOWN
Last Update Posted:
2022-08-03
First Post:
2022-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
Sponsor:
Peking University Third Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-09-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-15
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-09
First Submit QC Date:
None
Study First Post Date:
2022-08-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-02
Last Update Post Date:
2022-08-03
Last Update Post Date Type:
ACTUAL